PATENT CLAIM ANALYSIS

Application Number: 16239950
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-04
Patent Classification: ["514", "04400A"]

Abstract:
The invention relates to the novel long non-coding BARD1 RNA molecule BARD1 9′L, siRNAs for therapeutic use and methods for the detection of BARD1 9′L as well as a promoters driving the expression of BARD1 9′L.

Claim (Index 10):
A method for the prevention or treatment of cancer in a patient in need thereof comprising the steps of: i. identifying the expression of BARD1 9\u2032L in a sample of said patient, optionally quantifying the level of expression, ii. administering an effective amount of one or more siRNAs specifically interfering with the expression or function of BARD1 9\u2032L to patients who express BARD1 9\u2032L, preferably in a predefined amount or concentration.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 99.0
- Lexical Diversity: 1.35714
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14797148', '13817013', '15553097', '12430737', '14988275']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7216003161374961
- 35 USC 102 Novelty (BERT): 0.6033901920088836
- Combined Prediction Score: 0.7097793037246348
- Mean Citation Score: 341.78225
- Max Citation Score: 598.1582599999998
- Similarity Product: 424.2853013428186

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test